Related Experiment Video
Updated: Jun 9, 2026

How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
[On the mechanism of antimotion sickness effects of mexidol]
Abstract:
The path-clamp method used within the whole-cell configuration in experiments with convoluted medullar oblongata sections obtained from white mongrel male rats aged 13 to 17 days evidenced that 5 mV of mexidol caused 96 +/- 2% inhibition of the excitation postsynaptic current in neurons of the medial vestibular nucleus generated by the depolarization step of 10 mV (holding potential = -70 my). This means that the antimotion sickness effect of mexidol has its origin in the ion mechanisms with involvement of the glutamate- and GABAergic components, primarily inhibition of ion currents through channels of the NMDA-receptor complex.
Insights
Mexidol significantly inhibits excitatory postsynaptic currents in rat neurons, suggesting its anti-motion sickness effects stem from blocking ion channels, particularly NMDA-receptors.
Area of Science:
- Neuroscience
- Pharmacology
- Ion Channel Physiology
Background:
- Motion sickness is a debilitating condition.
- Mexidol is a potential therapeutic agent.
- Understanding its mechanism of action is crucial.
Purpose of the Study:
- To investigate the ion mechanisms underlying the anti-motion sickness effects of Mexidol.
- To determine the specific ion channels modulated by Mexidol in the medial vestibular nucleus.
Main Methods:
- Whole-cell patch-clamp recordings were performed on rat medullar oblongata slices.
- Experiments utilized convoluted medullar oblongata sections from young male rats.
- Excitation postsynaptic currents were measured under specific voltage-clamp conditions.
Main Results:
- 5 mV of Mexidol induced a 96 +/- 2% inhibition of excitatory postsynaptic currents.
- This inhibition was observed in neurons of the medial vestibular nucleus.
- The effect was linked to a 10 mV depolarization step and a holding potential of -70 mV.
Conclusions:
- Mexidol's anti-motion sickness properties are mediated by ion mechanisms.
- It involves modulation of glutamate and GABAergic components.
- Primarily, Mexidol inhibits ion currents through NMDA-receptor channels.
Related Concept Videos
Equilibrium and Balance
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Toxidromes: Clinical Features
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
